Home / Spain / Oryzon Genomics, S.A.
Oryzon Genomics, S.A.
ES0167733015 Short position disclosed on July 3, 2026.
0.63% of the capital sold short
1 disclosing funds
3 disclosures on record
Evolution of the disclosed total
Open positions
| Fund | % of capital | Since |
|---|---|---|
| Voleon Capital Management LP | 0.63% | July 3, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 3, 2026 | Voleon Capital Management LP | 0.63% | still open |
| May 18, 2026 | Qube Research & Technologies Ltd | 0.00% | still open |
| April 2, 2025 | Citadel Securities GCS (Ireland) Limited | 0.37% | still open |
Other companies sold short in Spain
- Indra Sistemas, S.A. 2.37% of the capital sold short
- Grifols, S.A. 1.99% of the capital sold short
- Enagas, S.A. 1.76% of the capital sold short
- Nyesa Valores Corporacion, S.A. 1.57% of the capital sold short
- Laboratorios Farmaceuticos Rovi, S.A. 1.51% of the capital sold short
- Repsol, S.A. 1.24% of the capital sold short
- Edreams Odigeo, S.A. 1.20% of the capital sold short
- Viscofan, S.A. 1.14% of the capital sold short
- Sacyr, S.A. 0.87% of the capital sold short
- Acciona, S.A. 0.78% of the capital sold short
- Ence Energia y Celulosa, S.A. 0.78% of the capital sold short
- Solaria Energia y Medioambiente, S.A. 0.76% of the capital sold short